Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Donald R. Wesson"'
Autor:
Donald R. Wesson, David E. Smith
Publikováno v:
Psychiatry. :1549-1560
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6c2e852e5a5633a129acaa65ecf702f
https://doi.org/10.1002/9781118753378.ch79
https://doi.org/10.1002/9781118753378.ch79
Publikováno v:
Alcoholism: Clinical & Experimental Research. 28:1051-1059
Background: Studies of the efficacy of naltrexone for alcohol dependence have yielded variable findings, which may be due, in part, to variation in compliance with oral naltrexone. Efforts to improve naltrexone compliance have included the developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d53c487f78cc092bbe185947d0a9085
https://doi.org/10.1097/01.alc.0000130804.08397.29
https://doi.org/10.1097/01.alc.0000130804.08397.29
Autor:
Walter Ling, Donald R. Wesson
Publikováno v:
Journal of Psychoactive Drugs. 35:253-259
The clinical opiate withdrawal scale (COWS) is a clinician-administered, pen and paper instrument that rates eleven common opiate withdrawal signs or symptoms. The summed score of the eleven items can be used to assess a patient's level of opiate wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae29dc611d2e5e7f1c0ab924e978980c
https://doi.org/10.1080/02791072.2003.10400007
https://doi.org/10.1080/02791072.2003.10400007
Autor:
Walter Ling, Donald R. Wesson
Publikováno v:
Drug and Alcohol Dependence. 70:S49-S57
Buprenorphine has been studied extensively since 1978 when it was initially proposed as an alternative to methadone for treatment of opioid dependence. Early work by Jasinski et al., 1978; Mello and Mendelson, 1980; Mello et al., 1982; Mello et al.,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc058c543322f45f8b3c11e32cef122
https://doi.org/10.1016/s0376-8716(03)00059-0
https://doi.org/10.1016/s0376-8716(03)00059-0
Autor:
Joseph Collins, Doralie Segal, Laura McNicholas, Steve Batki, Donald R. Wesson, John A. Renner, Paul Casadonte, Donald J. Tusel, Prudencia C. Kintaudi, Lawrence S. Brown, Carol Fye, Charles Charuvastra, Susan M. Stine, Erick Santos, Walter Ling, Richard I. H. Wang, Usha Malkerneker
Publikováno v:
Addiction. 93:475-486
Aims. To evaluate the safety and ef® cacy of an 8 mg/day sublingual dose of buprenorphine in the maintenance treatment of heroin addicts by comparison with a 1 mg/day dose over a 16-week treatment period. As a secondary objective, outcomes were dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed826cf0c299ea78ed471bb37600e5a
https://doi.org/10.1046/j.1360-0443.1998.9344753.x
https://doi.org/10.1046/j.1360-0443.1998.9344753.x
Autor:
Donald R. Wesson
Publikováno v:
Journal of Addictive Diseases. 25:1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adf8b6c5e840c91aeb0908ce1d283be3
https://doi.org/10.1300/j069v25n03_01
https://doi.org/10.1300/j069v25n03_01
Publikováno v:
The American Journal on Addictions. 5:220-230
The authors used pharmacological response criteria to determine the therapeutic dose range of buprenorphine for the treatment of opiate dependence. One hundred consecutively admitted patients with opiate addiction were followed for 16 weeks while rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9f78bd17646369754306809f25f37d
https://doi.org/10.1111/j.1521-0391.1996.tb00305.x
https://doi.org/10.1111/j.1521-0391.1996.tb00305.x
Publikováno v:
Journal of Psychoactive Drugs. 28:183-189
Flunitrazepam (Rohypnol) is a benzodiazepine sedative-hypnotic that has generated significant media attention in the United States because of its abuse and its association with "date rape." A field investigation was conducted in south Texas to ascert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb97fe7d2af345e4ec5ab5cd6fb58270
https://doi.org/10.1080/02791072.1996.10524390
https://doi.org/10.1080/02791072.1996.10524390
Publikováno v:
Journal of Addictive Diseases. 15:85-92
Clinical trials designed to establish the effectiveness of a pharmacotherapy for the treatment of drug abuse typically call for the collection and analysis of three urine samples per week to detect changes in drug use patterns. Examination of over 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9408910020aecdfecc08fd3a3f51fc72
https://doi.org/10.1300/j069v15n02_07
https://doi.org/10.1300/j069v15n02_07
Publikováno v:
Journal of Addictive Diseases. 14:97-114
The partial mu-opiate agonist, buprenorphine, is the subject of recent evaluation as a potential pharmacotherapy for cocaine dependence. This paper reviews the extant preclinical and clinical evidence of buprenorphine effectiveness in treating cocain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea54f30ea1264b435835d459e2ba146
https://doi.org/10.1300/j069v14n03_07
https://doi.org/10.1300/j069v14n03_07